Anirudh Khanna

Anirudh Khanna practices at Hackettstown Medical Center in Hackettstown, New Jersey, part of Atlantic Health System.

Anirudh Khanna's NPI, 1104909712, was assigned on October 24, 2006. Anirudh Khanna holds New Jersey license 25MA07069400.

Anirudh Khanna's primary practice is Hackettstown Medical Center, at 651 Willow Grove St, Hackettstown, NJ 07840 in Warren County. The practice phone is (908) 852-5100.

Anirudh Khanna's primary practice is Hackettstown Medical Center in Hackettstown, New Jersey, part of Atlantic Health System. Anirudh Khanna is also affiliated with Morristown Medical Center. The medical group on file is Cardiovascular Health Consultants, P.A. Dmand AI also links Anirudh Khanna to 3 more hospitals, 2 physician offices, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anirudh Khanna practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Anirudh Khanna's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Anirudh Khanna is licensed in New Jersey.

CMS data shows 15,136 Medicare services from Anirudh Khanna across 50 procedure codes in 2024, for 1,622 Medicare patients. Medicare paid $1,230,477 for them.

CMS counts 1,622 Medicare patients who saw Anirudh Khanna in 2024. The largest group is 75 to 84, with 607 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anirudh Khanna's median patient age at 69, with 44% women.

In 2024, Anirudh Khanna wrote 9,650 Medicare Part D claims for 1,094 patients. 86% of them were for generic drugs. CMS names the drug for 9,329 of them, across 69 drugs with 11 or more claims each, at $1,448,933 in total drug cost. In 2023, CMS named 8,393 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 21 out of 100 for Anirudh Khanna for performance year 2024, reported individually. Anirudh Khanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anirudh Khanna as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 395 general payments to Anirudh Khanna from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $759.